Targeted left ventricular lead positioning to the site of latest activation in cardiac resynchronization therapy: a systematic review and meta-analysis.
Targeted left ventricular lead positioning to the site of latest activation in cardiac resynchronization therapy: a systematic review and meta-analysis.
复制标题
DOI:
10.1093/europace/euad267
复制
发表时间:
2023-08-02
期刊:
影响因子:
6.1
通讯作者:
Nielsen, Jens Cosedis
中科院分区:
文献类型:
--
作者:
Fyenbo, Daniel Benjamin;Bjerre, Henrik Laurits;Frausing, Maria Hee Jung Park;Stephansen, Charlotte;Sommer, Anders;Borgquist, Rasmus;Bakos, Zoltan;Glikson, Michael;Milman, Anat;Beinart, Roy;Kockova, Radka;Sedlacek, Kamil;Wichterle, Dan;Saba, Samir;Jain, Sandeep;Shalaby, Alaa;Kronborg, Mads Brix;Nielsen, Jens Cosedis
关键词:
Several studies have evaluated the use of electrically- or imaging-guided left ventricular (LV) lead placement in cardiac resynchronization therapy (CRT) recipients. We aimed to assess evidence for a guided strategy that targets LV lead position to the site of latest LV activation. A systematic review and meta-analysis was performed for randomized controlled trials (RCTs) until March 2023 that evaluated electrically- or imaging-guided LV lead positioning on clinical and echocardiographic outcomes. The primary endpoint was a composite of all-cause mortality and heart failure hospitalization, and secondary endpoints were quality of life, 6-min walk test (6MWT), QRS duration, LV end-systolic volume, and LV ejection fraction. We included eight RCTs that comprised 1323 patients. Six RCTs compared guided strategy (n = 638) to routine (n = 468), and two RCTs compared different guiding strategies head-to-head: electrically- (n = 111) vs. imaging-guided (n = 106). Compared to routine, a guided strategy did not significantly reduce the risk of the primary endpoint after 12–24 (RR 0.83, 95% CI 0.52–1.33) months. A guided strategy was associated with slight improvement in 6MWT distance after 6 months of follow-up of absolute 18 (95% CI 6–30) m between groups, but not in remaining secondary endpoints. None of the secondary endpoints differed between the guided strategies. In this study, a CRT implantation strategy that targets the latest LV activation did not improve survival or reduce heart failure hospitalizations.
登录
查看更多内容
影响因子:
2.1
作者:
Jin Y;Zhang Q;Mao JL;He B
通讯作者:
He B
影响因子:
1.9
作者:
Sami, Abdul;Mustafa, Bilal;Butt, Hamza Ahmed;Ashraf, Zainab;Ullah, Asif;Babar, Farheen;Asad, Muhammad;Awais, Muhammad;Zaidi, Syed Muhammad Jawad;Fakhar, Tehniat;Mehmoodi, Amin;Adnan, Nawal;Malik, Jahanzeb
通讯作者:
Malik, Jahanzeb
影响因子:
37.8
作者:
Delgado, Victoria;van Bommel, Rutger J.;Bax, Jeroen J.
通讯作者:
Bax, Jeroen J.
影响因子:
18.2
作者:
Bertini, Matteo;Mele, Donato;Ferrari, Roberto
通讯作者:
Ferrari, Roberto
影响因子:
13
作者:
Kydd, Anna C.;Khan, Fakhar Z.;Dutka, David P.
通讯作者:
Dutka, David P.